Journal of Ovarian Research

Papers
(The H4-Index of Journal of Ovarian Research is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The role of oxidative stress in ovarian aging: a review95
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment84
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective82
Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age48
The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis44
Therapeutic role of curcumin and its novel formulations in gynecological cancers42
An overview of FSH-FSHR biology and explaining the existing conundrums42
Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses41
Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer41
Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis38
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells38
Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis37
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized37
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells37
Targeting purine metabolism in ovarian cancer37
Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1/Akt in granulosa cells of PCOS36
MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer36
Mechanisms of ovarian aging in women: a review35
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A33
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging33
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer31
Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells31
Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis30
The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal‐weight population30
Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients27
RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis27
0.046035051345825